HPV16/18 L1 VLP Vaccine Induces Cross-Neutralizing Antibodies that May Mediate Cross-Protection

Human papillomavirus (HPV) L1 VLP-based vaccines are protective against HPV vaccine-related types; however, the correlates of protection have not been defined. We observed that vaccination with Cervarix™ induced cross-neutralizing antibodies for HPV types for which evidence of vaccine efficacy has b...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kemp, Troy J., Hildesheim, Allan, Safaeian, Mahboobeh, Dauner, Joseph G., Pan, Yuanji, Porras, Carolina, Schiller, John T., Lowy, Douglas R., Herrero, Rolando, Pinto, Ligia A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3046309/
https://ncbi.nlm.nih.gov/pubmed/21241731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.01.001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak